Table 2.
Ophthalmic complications and visual outcome
| Patients | Follow up (months) | Complications | Preop BCVA | Obtained BCVA during the follow up | Final BCVA |
| 1 | 24 | Endophthalmitis | LP | 0.1 | LP |
| 2 | 11 | None | LP | LP | LP |
| 3 | 8 | Extrusion | LP | LP | LP |
| 4 | 24 | Endophthalmitis, extrusion | LP | HM | NLP |
| 5 | 43 | RD, endophthalmitis | LP | 0.1 | NLP |
| 6 | 33 | RD, phthisis | CF | LP | NLP |
| 7 | 46 | Extrusion | LP | HM | LP |
| 8 | 26 | RD, extrusion | LP | LP | NLP |
| 9 | 57 | Endophthalmitis | HM | 0.2 | NLP |
| 10 | 23 | Endophthalmitis, phthisis | LP | LP | LP |
| 11 | 60 | None | LP | HM | HM |
LP, light perception; NLP, no light perception; HM, hand movement.